Ocular Therapeutix (OCUL) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of$0.24. This compares to loss of $0.28 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -20.83$0.23 per share when it actually produced a loss of $0.26, delivering a surprise of -13.04%.Over the last four quarters, the c ...